Metin Kurtoglu, CTO: Cartesian Therapeutics RNAC Sell · Filed 24/11/18

Trade details

Type: Insider sale
Amount: $379,569.6
Shares · price: 22,068 sh · $17.20 a share
Held after: 51,033 sh
Stock: Cartesian Therapeutics RNAC
Person: Metin KurtogluCTO
Trade date: 24/11/15
Filed: 24/11/18
Days to filing: 3 days

Sold 30.2% of holdings

Share of holding sold: 30.2%

Cartesian Therapeutics trades, last 26 weeks

What else happened in Cartesian Therapeutics around then

Filed or reported within 30 days of the trade day · 24/10/16~24/12/15

Metin Kurtoglu's recent trades

Metin KurtogluCTO
SellCartesian Therapeutics
Sell
Cartesian Therapeutics
RNAC
$41.4K
2,458 sh
$41.4K
Filed 25/01/07
Traded 25/01/06
Metin KurtogluCTO
SellCartesian Therapeutics
Sell
Cartesian Therapeutics
RNAC
$40.4K
2,417 sh
$40.4K
Filed 25/01/07
Traded 25/01/03
Metin KurtogluCTO
SellCartesian Therapeutics
Sell
Cartesian Therapeutics
RNAC
$157.2K
6,224 sh
$157.2K
Filed 24/12/11
Traded 24/12/09
Metin KurtogluCTO
SellCartesian Therapeutics
Sell
Cartesian Therapeutics
RNAC
$117.2K
4,539 sh
$117.2K
Filed 24/12/11
Traded 24/12/09
Metin KurtogluCTO
SellCartesian Therapeutics
Sell
Cartesian Therapeutics
RNAC
$70.6K
2,901 sh
$70.6K
Filed 24/12/11
Traded 24/12/10

Metin Kurtoglu, CTO — sold $379.6K of Cartesian Therapeutics RNAC · 30.2% of holdings | Whalegun